The Effect High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology
Primary Purpose
Hip Joint, Muscle Weakness
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hip mobilization
Hip manipulation simulation
Sponsored by
About this trial
This is an interventional treatment trial for Hip Joint
Eligibility Criteria
Inclusion Criteria:
- Individuals with a lower extremity pathology volunteered for this study
- Being greater than 18 years of age
- 10% decrease in muscle strength in symptomatic side compared to healthy side
- Absence of medical precautions that would prevent a maximal effort strength test.
Exclusion Criteria:
- Included individuals with a history lower extremity arthroplasty.
- Recent muscle or tendon ruptures (within the past 6 months)
- Unhealed fractures
- Neurological diseases
- Malignant cancer
- Osteoporosis
- Active infections processes
- Early postoperative knee, hip and ankle surgery with range of motion and weight bearing restrictions.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Placebo Group
Manipulation Group
Arm Description
Hip manipulation simulation
Hip manipulation
Outcomes
Primary Outcome Measures
Muscle strength
A Lafayette dynamometer was used to evaluate the maximum isometric torque of the muscles
Secondary Outcome Measures
Full Information
NCT ID
NCT03115879
First Posted
March 23, 2017
Last Updated
April 11, 2017
Sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
1. Study Identification
Unique Protocol Identification Number
NCT03115879
Brief Title
The Effect High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology
Official Title
The Effect of High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
February 2015 (Actual)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Introduction: Lower extremity weakness associated with musculoskeletal pathology can cause activity limitations. Physical therapy intervention in the form of exercise is commonly directed at improving muscular performance, however, neuromuscular adaptations may limit the effectiveness of traditional strengthening exercises. Manual therapy techniques have been used as a disinhibitory intervention to increase muscle activation and strength before participating in strengthening exercises or performing functional tasks While there is recent evidence to support joint mobilization as a valuable manual therapy disinhibitory intervention Currently, there is no evidence to substantiate anecdotal experience that a HVLAT hip distraction mobilization improves muscle performance in subjects with lower extremity pathology and lower extremity weakness. The purpose of this study was to determine if a HVLAT hip distraction mobilization would result in an immediate change of maximal force output of the quadriceps, gluteus maximus and gluteus medius.
Methods: Forty individuals with a lower extremity pathology volunteered for this study. Inclusion criteria were having a unilateral musculoskeletal pathology, being greater than 18 years of age, 10% decrease in muscle strength in symptomatic side compared to healthy side, and absence of medical precautions that would prevent a maximal effort strength test and exclusion criteria included individuals with a history lower extremity recent muscle or tendon ruptures (within the past 6 months) and postoperative knee, hip and ankle surgery. Demographic data, including diagnosis from referring physician were collected. All subjects completed the Lower extremity function scale (LEFS). A single evaluator blinded to the involved extremity was responsible for quadriceps, gluteus medius and maximus strength analysis pre and post mobilization of both symptomatic and non-symptomatic sides. The subject underwent the HVLAT hip distraction mobilization of the symptomatic side, and an immediate re-assessment of strength of both symptomatic and non-symptomatic sides followed the mobilization.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Joint, Muscle Weakness
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo Group
Arm Type
Placebo Comparator
Arm Description
Hip manipulation simulation
Arm Title
Manipulation Group
Arm Type
Experimental
Arm Description
Hip manipulation
Intervention Type
Other
Intervention Name(s)
Hip mobilization
Intervention Description
High velocity low amplitude hip mobilization of the experimental group
Intervention Type
Other
Intervention Name(s)
Hip manipulation simulation
Intervention Description
Hip manipulation simulation
Primary Outcome Measure Information:
Title
Muscle strength
Description
A Lafayette dynamometer was used to evaluate the maximum isometric torque of the muscles
Time Frame
Assessment of muscle strength was performed after 10 minutes of manipulation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Individuals with a lower extremity pathology volunteered for this study
Being greater than 18 years of age
10% decrease in muscle strength in symptomatic side compared to healthy side
Absence of medical precautions that would prevent a maximal effort strength test.
Exclusion Criteria:
Included individuals with a history lower extremity arthroplasty.
Recent muscle or tendon ruptures (within the past 6 months)
Unhealed fractures
Neurological diseases
Malignant cancer
Osteoporosis
Active infections processes
Early postoperative knee, hip and ankle surgery with range of motion and weight bearing restrictions.
12. IPD Sharing Statement
Learn more about this trial
The Effect High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology
We'll reach out to this number within 24 hrs